Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 98

Sort by

Sort Order Select

Journal Articles

Comprehensive Analysis of MYC Translocations in Multiple Myeloma By Whole Genome Sequencing and Whole Transcriptome Sequencing

Sonja Seliger, Verena Geirhos, Torsten Haferlach, MD, Wolfgang Kern, MD, Wencke Walter, PhD, Manja Meggendorfer, PhD, Constance Baer, PhD, Anna Stengel, PhD, Claudia Haferlach, MD

Blood (2019) 134 (Supplement_1): 1774.

https://doi.org/10.1182/blood-2019-124704

Published: 2019

Journal Articles

Efficacy of Early Convert to Dasatinib in Chronic Myeloid Leukemia Patients Who Inresponse or Intolerance to Imatinib

Liu Liang, Na Xu, PhD, Xuan Zhou, PhD, Huang JiXian, Chen Chen, Lin Tong, Wu wan-Er, Changxin Yin, Qifa Liu, MD, Liu Xiaoli, MD

Blood (2018) 132 (Supplement 1): 5430.

https://doi.org/10.1182/blood-2018-99-114120

Published: 2018

Journal Articles

Detection of the BCR-ABL Gene By the Real-Time PCR Method in Patients with Chronic Myeloid Leukemia in Rio Grande Do Norte, Brazil

Aldair Sousa Paiva, PhD, Hugo Diogenes De Oliveira Paiva, MD, Geraldo Barroso Cavalcanti, Jr., PhD, Gioconda DR Leão, PhD, Marcos Dias Leão, PhD, Roberto C Vasconcelos, MD, Andrea LAC Fernandes, PhD, Frank Bahia, MD, Victor lima Soares, Erica Aires Gil, MD, Geisa Januario, Karla Cristina Santos, Telma Araujo Lemos, Alessandra Suelen Jardim

Blood (2018) 132 (Supplement 1): 5432.

https://doi.org/10.1182/blood-2018-99-118853

Published: 2018

Journal Articles

Identification of a Novel BCR-ABL1 Fusion Transcript in a Chronic Myeloid Leukemia (CML) Patient By Unique Molecular Methods and Subsequent Monitoring of the Patient's Response to Tyrosine Kinase Inhibitor (TKI) Therapy

Durga Prasad Dash, PhD, Valerie Trap-stamborski, PhD, Curt Czajkowski, MT(ASCP), CLSp(MB), Daniel Rauscher, CLS (ASCP), Raju Pillai, MD

Blood (2018) 132 (Supplement 1): 5453.

https://doi.org/10.1182/blood-2018-99-119219

Published: 2018

Journal Articles

Cytotoxic Immune Response Can be Obtained Earlier in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Dasatinib Than with Other Tyrosine Kinase Inhibitors

Tatsuro Jo, MD PhD, Yohei Kaneko, Kazuhiro Noguchi, Shizuka Hayashi, Risa Hayase, Haruna Shioya, Sadaharu Irie, Kensuke Horio, MD, Jun Taguchi, MD PhD

Blood (2018) 132 (Supplement 1): 3016.

https://doi.org/10.1182/blood-2018-99-113316

Published: 2018

Journal Articles

The Landscape of Structural Variant Signatures in Multiple Myeloma Identifies Distinct Disease Subgroups with Implications for Pathogenesis

Francesco Maura, Daniel Leongamornlert, BS, Nicos Angelopoulos, PhD, Kevin J Dawson, Mehmet Kemal Samur, PhD, Raphael Szalat, MD, Yu-Tzu Tai, PhD, Stephane Minvielle, PhD, Florence Magrangeas, Philippe Moreau, Paolo Corradini, MD, Kenneth C. Anderson, MD, Hervé Avet-Loiseau, MDPhD, Peter J. Campbell, PhD, Nikhil Munshi, MD, Niccolò Bolli

Blood (2018) 132 (Supplement 1): 109.

https://doi.org/10.1182/blood-2018-99-112420

Published: 2018

Journal Articles

Hematologic Response and Frequency of Side Effects in Chronic Myeloid Leukemia Patients Treated with Imatinib (GLIVEC): A South-East Asian Experience

Hafiz M Aslam, MD MBBS, Iqbal M Shumaila, Ambreen A Merchant, Mariam G Muhammad, Javeria Yasir, Faizan A Faizee, Madiha A Qadir

Blood (2017) 130 (Supplement 1): 5257.

https://doi.org/10.1182/blood.V130.Suppl_1.5257.5257

Published: 2017

Journal Articles

Characterization of Ex-Vivo PTCH1 Expression Under Tyrosine Kinase Inhibitors Treatment and Determination of Downstream Effectors Oh Hedgehog Pathway in CML

Juan Manuel Alonso Dominguez, MD PhD MSc, Alicia Arenas, PhD, Pilar Llamas, MDPhD, Diego Velasco, Aránzazu García-Raso, PhD, Jose Luis Lopez Lorenzo, MD, Mireia Atance, Rocio N Salgado, PhD, Joaquin Martinez Lopez, MD PhD

Blood (2017) 130 (Supplement 1): 5245.

https://doi.org/10.1182/blood.V130.Suppl_1.5245.5245

Published: 2017

Journal Articles

Dasatinib-Induced Lymphocyte Elevation and Imbalance of T Cell Receptor V Beta Gene Expression in Chronic Phase Chronic Myelogenous Leukemia Patients

Tatsuro Jo, MD PhD, Sadaharu Irie, Kazuhiro Noguchi, Shizuka Hayashi, Risa Hayase, Haruna Shioya, Yohei Kaneko, Kensuke Horio, MD, Jun Taguchi, MD PhD

Blood (2017) 130 (Supplement 1): 1613.

https://doi.org/10.1182/blood.V130.Suppl_1.1613.1613

Published: 2017

Journal Articles

B Cell-Derived Induced Pluripotent Stem Cells Are Useful for Determining the Cellular Origin of Abnormal B Cells in Multiple Myeloma

Aki Yanagi, Fumihiko Kawamura, MS, Makoto Inaki, PhD, Atsushi Katafuchi, PhD, Yukari Yanai, MS, Yu Abe, MD, Naohiro Tsuyama, PhD, Misaki Sugai, BS, Mitsunori Higuchi, MD PhD, Satoshi Muto, MD PhD, Takumi Yamaura, MD, Hiroyuki Suzuki, MD PhD, Hideyoshi Noji, MD PhD, Shinichi Suzuki, MD PhD, Yoshida A Mitsuaki, PhD, Megumi Sasatani, PhD, Kenji Kamiya, MD PhD, Masafumi Onodera, MD PhD, Akira Sakai, MDPhD

Blood (2017) 130 (Supplement 1): 1808.

https://doi.org/10.1182/blood.V130.Suppl_1.1808.1808

Published: 2017

Journal Articles

Expression Profiling of Micro RNAs (MiRNAs) and Long Non-Coding RNAs (lncRNAs) in Chronic Myeloid Leukemia (CML) Patients in the State of Qatar

Nader I. Al-Dewik, PhD, Salsabel Elshami, BSc, Nada Nasser, BSc, Mohammed Alsharshani, BSc, Mohammed Araby, MSc, Mohamed A. Yassin, MBBS, MSc, Pejman H. Moghaddam, PhD

Blood (2017) 130 (Supplement 1): 5243.

https://doi.org/10.1182/blood.V130.Suppl_1.5243.5243

Published: 2017

Journal Articles

Parthenolide and DMAPT Induce Cell Death in Chronic Myeloid Leukemia Cells Via Generation of Reactive Oxygen Species

Gabriela Flores-López, PhD Candidate, Hector Mayani, PhD, María Antonieta Chávez-Gonzalez, PhD

Blood (2016) 128 (22): 4242.

https://doi.org/10.1182/blood.V128.22.4242.4242

Published: 2016

Journal Articles

Targeting Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia with a Novel Transcriptional Inhibitor

Shintaro Maeda, Ken Morita, MD, PhD, Kensho Suzuki, Hiroshi Sugiyama, PhD, Souichi Adachi, MD, PhD, Yasuhiko Kamikubo, MD, PhD

Blood (2016) 128 (22): 2737.

https://doi.org/10.1182/blood.V128.22.2737.2737

Published: 2016

Journal Articles

Clinical Characteristics and Treatment with Various Tyrosine Kinase Inhibitors in Patients with ETV6-ABL1 positive Eosinophilia-Associated Myeloproliferative Neoplasms

Andreas Reiter, MD, Gunay Ahmadova, MD, Mohamad Jawhar, MD, Andres Virchis, MD, Tim Somervaille, MDPhD, Mark Williams, MD, Bernd Schönberger, MD, Rebecca Frewin, FRCPath, MRCP, MBBS, BSc, Philipp J. Jost, MD, Annett Maschke, MD, Peter Keller, MD, Torsten Haferlach, MD, Nicole Naumann, Juliana Schwaab, MD, Alice Fabarius, PhD, Wolf-Karsten Hofmann, MD, Claudia Haferlach, MD, Nicholas C.P. Cross, PhD, Georgia Metzgeroth, MD

Blood (2016) 128 (22): 3114.

https://doi.org/10.1182/blood.V128.22.3114.3114

Published: 2016

Journal Articles

Rearrangements of Tyrosine Kinase (TK) Genes in Chronic Myeloproliferative Disorders (CMPD): A FISH Study

Paolo Bernasconi, MD, Irene Dambruoso, Marina Boni, Paola Maria Cavigliano, Ilaria Giardini, Barbara Rocca, Rita Zappatore, Marilena Caresana, Antonella Orlando, Ilaria Casetti, MD, Chiara Elena, MD, Elisa Rumi, MD, Mario Cazzola, MD

Blood (2016) 128 (22): 5493.

https://doi.org/10.1182/blood.V128.22.5493.5493

Published: 2016

Journal Articles

Risk of Monoclonal Gammopathy of Undetermined Significance in First-Degree Relatives of Multiple Myeloma Cases By Cytogenetic Subtype

Alyssa I. Clay, PhD, Abdul Rishi, MBBS, Shaji Kumar, MD, S. Vincent Rajkumar, MD, Alexandra J. Greenberg, PhD MPH, Dirk R Larson, MS, Megan M. O'Byrne, MS, Susan L. Slager, PhD, Celine M. Vachon, PhD

Blood (2016) 128 (22): 4425.

https://doi.org/10.1182/blood.V128.22.4425.4425

Published: 2016

Journal Articles

Clincial and Genetic Landscapes Differ Between IGH-CRLF2 and P2RY8-CRLF2 Acute Lymphoblastic Leukaemia

Lisa Jane Russell, PhD, Lisa Jones, BSc, Amir Enshaei, PhD, Jamie Rutherford, BSc, Stefano Tonin, PhD, Sarra Ryan, PhD, Jeyanthy Eswaran, PhD, Elli Papaemmanuil, PhD, Jose Tubio, PhD, Peter J Campbell, MD PhD, Anthony V Moorman, PhD, Christine Harrison, PhDFRCPath FMedSci

Blood (2015) 126 (23): 1426.

https://doi.org/10.1182/blood.V126.23.1426.1426

Published: 2015

Journal Articles

Lymphoid Lineage Preference of MLL-AF4 Is Revealed in a Species-Specific Model

Shan Lin, Roger T. Luo, PhD, Mark Wunderlich, MS, Joseph J. Kaberlein, Ahmad Rayes, MDMSc, John Anastasi, MD, Maureen M O'Brien, MD, James C. Mulloy, PhD, Michael J. Thirman, MD

Blood (2015) 126 (23): 2454.

https://doi.org/10.1182/blood.V126.23.2454.2454

Published: 2015

Journal Articles

Exploring the Significance of TP53, ABCB1 and GST Polymorphisms on Susceptibility and Pharmacogenetics in Argentinian Patients with Chronic Myeloid Leukemia

Natalia Weich, Master in Science, Cristian Ferri, PhD, Elena Beatriz Moiraghi, MD, Raquel Maria Nelida Bengio, MD, Isabel Amanda Giere, PhD M.Sc, Carolina Pavlovsky, MD, Irene Larripa, PhD, Ariela Freya Fundia, PhD

Blood (2015) 126 (23): 5134.

https://doi.org/10.1182/blood.V126.23.5134.5134

Published: 2015

Journal Articles

Acute Promyelocytic Leukemia: An Unsual Presentation

Mary Kay Vaske, MD, Adeola Tomi-Olugbodi, MD, Indumathy Varadarajan, MD, J. Steve Hou, MD

Blood (2015) 126 (23): 4977.

https://doi.org/10.1182/blood.V126.23.4977.4977

Published: 2015

NARROW

Comprehensive Analysis of MYC Translocations in Multiple Myeloma By Whole Genome Sequencing and Whole Transcriptome Sequencing

Efficacy of Early Convert to Dasatinib in Chronic Myeloid Leukemia Patients Who Inresponse or Intolerance to Imatinib

Detection of the BCR-ABL Gene By the Real-Time PCR Method in Patients with Chronic Myeloid Leukemia in Rio Grande Do Norte, Brazil

Identification of a Novel BCR-ABL1 Fusion Transcript in a Chronic Myeloid Leukemia (CML) Patient By Unique Molecular Methods and Subsequent Monitoring of the Patient's Response to Tyrosine Kinase Inhibitor (TKI) Therapy

Cytotoxic Immune Response Can be Obtained Earlier in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Dasatinib Than with Other Tyrosine Kinase Inhibitors

The Landscape of Structural Variant Signatures in Multiple Myeloma Identifies Distinct Disease Subgroups with Implications for Pathogenesis

Hematologic Response and Frequency of Side Effects in Chronic Myeloid Leukemia Patients Treated with Imatinib (GLIVEC): A South-East Asian Experience

Characterization of Ex-Vivo PTCH1 Expression Under Tyrosine Kinase Inhibitors Treatment and Determination of Downstream Effectors Oh Hedgehog Pathway in CML

Dasatinib-Induced Lymphocyte Elevation and Imbalance of T Cell Receptor V Beta Gene Expression in Chronic Phase Chronic Myelogenous Leukemia Patients

B Cell-Derived Induced Pluripotent Stem Cells Are Useful for Determining the Cellular Origin of Abnormal B Cells in Multiple Myeloma

Expression Profiling of Micro RNAs (MiRNAs) and Long Non-Coding RNAs (lncRNAs) in Chronic Myeloid Leukemia (CML) Patients in the State of Qatar

Parthenolide and DMAPT Induce Cell Death in Chronic Myeloid Leukemia Cells Via Generation of Reactive Oxygen Species

Targeting Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia with a Novel Transcriptional Inhibitor

Clinical Characteristics and Treatment with Various Tyrosine Kinase Inhibitors in Patients with ETV6-ABL1 positive Eosinophilia-Associated Myeloproliferative Neoplasms

Rearrangements of Tyrosine Kinase (TK) Genes in Chronic Myeloproliferative Disorders (CMPD): A FISH Study

Risk of Monoclonal Gammopathy of Undetermined Significance in First-Degree Relatives of Multiple Myeloma Cases By Cytogenetic Subtype

Clincial and Genetic Landscapes Differ Between IGH-CRLF2 and P2RY8-CRLF2 Acute Lymphoblastic Leukaemia

Lymphoid Lineage Preference of MLL-AF4 Is Revealed in a Species-Specific Model

Exploring the Significance of TP53, ABCB1 and GST Polymorphisms on Susceptibility and Pharmacogenetics in Argentinian Patients with Chronic Myeloid Leukemia

Acute Promyelocytic Leukemia: An Unsual Presentation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only